Repetitive transcranial magnetic stimulation versus botulinum toxin injection in chronic migraine prophylaxis: a pilot randomized trial

Hatem Shehata(Cairo University), Nevin Shalaby(Cairo University), Asmaa Sabbah(Cairo University), Alaa Elmazny(Cairo University), Eman Esmail(Cairo University), Shaimaa I El-Jaafary(Cairo University), Ahmed Abdelalim
Journal of Pain Research
October 1, 2016
10.2147/jpr.s116671
Cited by 47

Related Papers

Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|14k
Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|8.7k
Global, regional, and national comparative risk assessment of 84 behavioural, environmental and occupational, and metabolic risks or clusters of risks for 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|5k
Global, regional, and national age-sex-specific mortality and life expectancy, 1950–2017: a systematic analysis for the Global Burden of Disease Study 2017
|The Lancet|2018|1.2k
Global, regional, and national burden of brain and other CNS cancer, 1990–2016: a systematic analysis for the Global Burden of Disease Study 2016
|The Lancet Neurology|2019|646